Brief: ADC Therapeutics Q4 Net Income USD -30.727 Million
27/03/2025 12:40
March 27 (Reuters) - ADC Therapeutics SA ADCT.N: ADC THERAPEUTICS Q4 NET INCOME USD -30.727 MILLION ADC THERAPEUTICS Q4 OPERATING EXPENSES USD -49.346 MILLION ADC THERAPEUTICS Q4 BASIC EPS USD -0.29 ADC THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -32.436 MILLION $250.9M IN CASH AS OF DECEMBER 31, 2024, PROVIDES RUNWAY EXPECTED TO FUND OPERATIONS INTO SECOND HALF OF 2026 Source text: ID:nPn37Y0xza Further company coverage: ADCT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview